Polylysine grafted polymer and method for preparing the same, polymer-modified microfluidic chip and detection device comprising the same

By modifying the surface of a microfluidic chip with a lysine-grafted polymer, the problem of non-specific adsorption was solved, the chip's sensitivity and practicality were improved, and more efficient biological detection was achieved.

CN117126398BActive Publication Date: 2026-11-10BOE TECHNOLOGY GROUP CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202210557345.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-05-20
Publication Date
2026-11-10
Estimated Expiration
2042-05-20

AI Technical Summary

Technical Problem

Existing microfluidic chip surface modification methods suffer from non-specific adsorption problems, resulting in low sensitivity and poor practicality of bioanalytes. Polyethylene glycol derivatives also have drawbacks such as difficulty in functionalization and slow biodegradation.

Method used

The surface of a microfluidic chip is modified with lysine-grafted polymers. Lysine molecules can easily branch to form multi-reactive functional groups and alkoxy functional groups to suppress the non-specific adsorption of biomolecules. The preparation methods include ring-opening polymerization of lysine-N-carboxyl anhydride and dehydration condensation of lysine α-amino group. The synthesis is simple and can be uniformly distributed at the chip interface.

Benefits of technology

It significantly reduces the non-specific adsorption of nucleic acids, proteins, and cells, improves the sensitivity and practicality of microfluidic chips, and enhances the effectiveness of biological detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117126398B_ABST
    Figure CN117126398B_ABST
Patent Text Reader

Abstract

The present application provides a lysine graft polymer. The polymer comprises a main chain formed by polymerization of lysine monomers, side chains formed by lysine grafting, and the side chains contain one or more reactive functional groups for coupling reaction with molecules containing alkoxy units to obtain hydrophilic side chain tails. When the lysine graft polymer is used to modify a microfluidic chip, the main chain of the graft polymer is a hydrophobic peptide bond, and the side chain is a hydrophilic group, so the graft polymer is arranged in a regular spiral structure at the chip interface, and the uniform distribution of hydrophilic units can greatly reduce the defects of the chip interface, further reduce the non-specific adsorption of the chip interface to nucleic acids, proteins and cells, thereby helping to improve the sensitivity and practicability of the chip in biological detection. The present application also provides a preparation method of the above-mentioned lysine graft polymer, a microfluidic chip modified by the above-mentioned lysine graft polymer and a monitoring device comprising the microfluidic chip.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biomedical technology, and particularly relates to a polylysine grafted polymer and its modified microfluidic chip and a detection device containing the chip. Background Technology

[0002] Microfluidic chips, also known as lab-on-a-chip or biochips, utilize microelectromechanical fabrication (MEMS) technology to miniaturize a large laboratory system onto a glass or plastic substrate, thereby replicating the entire process of complex biological and chemical reactions and completing experiments rapidly and automatically. Their key feature is the construction of fluid-containing channels, reaction chambers, and other functional components at the micrometer scale, manipulating the movement of minute amounts of fluid within a tiny space to create a complete chemical or biological laboratory.

[0003] Microfluidic chips generally consist of two parts: a substrate and a structure. The substrate is typically made of glass or silicon, while the structure is often composed of micrometer-scale fluid channels, i.e., microchannels, built from glass or polymers such as PDMS, PMMA, and SU8. The surface properties of these microchannels largely determine the function and application areas of the microfluidic chip. However, many microfluidic chips made of materials including glass and polymers, due to their charged surfaces or strong hydrophobicity, severely affect fluid introduction, flow, solute adsorption, and related electrohydrodynamic effects. This greatly limits the range of analytes that can be analyzed and reduces the sensitivity and practicality of the microfluidic chip.

[0004] To address the aforementioned technical challenges, appropriate molecular modifications to the surface of microfluidic chips are typically required to improve chip performance and enhance sensitivity. Currently, the primary interface modification method for glass-based microfluidic chips involves covalently modifying polyethylene glycol (PEG). PEG is believed to strongly bind water molecules, forming a physical or energy barrier that keeps proteins, nucleic acids, platelets, and cells away from the matrix surface. Furthermore, PEG's excellent biocompatibility has led to its widespread application in solution antibacterial, surface antifouling, and drug delivery. However, PEG still suffers from several drawbacks, such as difficulty in functionalization, very slow biodegradation, and uneven film thickness on glass surfaces, significantly hindering further improvements in chip performance.

[0005] Therefore, developing new molecular modifiers or polyethylene glycol derivatives for chip interface modification to achieve non-specific "zero" adsorption of bioanalytes is crucial for the application of microfluidic technology in biomedical and diagnostic research, and is also one of the urgent problems to be solved in the field of interface chemistry. Summary of the Invention

[0006] To address the problems of non-specific adsorption at the interface of existing microfluidic chips, which leads to low sensitivity and poor practicality in bioanalysis and detection, this invention develops a lysine-grafted polymer and its modified microfluidic chip, along with a detection device containing the chip, by combining the property that lysine molecules easily branch to form multi-reactive functional groups and the property that alkoxy functional groups can inhibit non-specific adsorption of biomolecules.

[0007] In a first aspect, the present invention provides a lysine-grafted polymer having the structure shown in formula (I):

[0008]

[0009] Where 10≤n≤50, R' is a tail chain group that can bond to the chip interface, and R1 has the structure shown in any one of formulas (II)-(IV).

[0010]

[0011] Wherein, R2 has the structure shown in any of the terms (V)-(VI),

[0012]

[0013] Where 2 ≤ m ≤ 10. In the structural formula of this invention... This indicates the connection site.

[0014] In a specific embodiment of the present invention, it is preferred that 15 ≤ n ≤ 25 in formula (I). As n increases, the dispersion of the polymer also increases, and excessive dispersion is not conducive to the modification of the chip interface by the polymer. When 15 ≤ n ≤ 25, the modification effect of the polymer on the chip interface is better; in formula (I), n is further preferably 15, 18, 20, 22 or 25.

[0015] As a specific embodiment of the present invention, when the polymer binds to the chip interface through hydrophobic interaction, R' is preferably an alkyl carbon chain group; more preferably, R' has the structure shown in any one of formulas (VII)-(VIII).

[0016]

[0017] Where 5≤z≤20; 2≤y≤8.

[0018] As a specific embodiment of the present invention, when the polymer is covalently bonded to the chip interface, preferably, the main chain or side chain of R' contains siloxy or silane groups at its ends; more preferably, the main chain or side chain of R' contains oligoethylene glycol linking chains; and even more preferably, R' has the structure shown in any one of formulas (IX)-(X).

[0019]

[0020] Where 5≤z≤20.

[0021] In a specific embodiment of the present invention, 3 ≤ m ≤ 6 is preferred in formula (V). For the grafted polymers provided in this disclosure, from a synthetic perspective, 2 ≤ m ≤ 10 can all be prepared. However, the larger m is, the lower the yield of the corresponding polymer will be due to steric hindrance. When m exceeds 10, almost no product is produced. Regarding its modification effect on the chip surface, the effect of m = 2 is similar to that of oligoethylene glycol, while when 3 ≤ m ≤ 6, its effect is superior to that of oligoethylene glycol. Considering all factors, 3 ≤ m ≤ 6 is preferred, as it ensures both a high synthetic yield and excellent modification performance. In formula (V), m is further preferably 3, 4, 5, or 6.

[0022] As a specific embodiment of the present invention, the sugar ring structure in Formula VI is preferably an oligosaccharide structure, and more preferably, the oligosaccharide structure is a mannose structure, a dismannose structure, or a trimannose structure.

[0023] The present invention does not specifically limit the preparation method of the lysine grafted polymer, which can be prepared by lysine-N-carboxyl ring-opening anhydride polymerization and lysine α-amino dehydration condensation. The former can be further divided into pre-polymerization ε-amino branching modification and post-polymerization ε-amino branching modification. Correspondingly, the dehydration condensation method also includes two similar schemes. Specific steps can be carried out according to methods well known to those skilled in the art, preferably referring to the following methods:

[0024] (1) ε-amino protection: The ε-amino group of the lysine-N-carboxy ring anhydride is protected, such as by tert-butyloxycarbonyl (Boc) or benzyloxycarbonyl (Cbz).

[0025] (2) Polymerization reaction: Lysine-N-carboxyl anhydride (molecule 1) protected by ε-amino ring is ring-opened polymerized under the action of an initiator, and then the protecting group is removed under the action of strong organic acid (such as TFA, p-toluenesulfonic acid) to obtain α-polylysine (molecule 2).

[0026] The initiator is terminated by an amino-containing alkyl carbon chain or an ethoxy chain, and may contain aromatic ring structures and heteroatom groups. When covalently bonded to the chip interface, the main chain or side chain of the initiator must contain siloxy or silane groups at its end; the terminal structure of the initiator includes, but is not limited to, the following structures:

[0027]

[0028] Where 5≤z≤20; 2≤y≤8.

[0029] The catalysts are strong organic acids such as trifluoroacetic acid (TFA) and p-toluenesulfonic acid.

[0030] (3) Grafting reaction: α-polylysine undergoes a condensation reaction with 2,6-di-tert-butoxycarbonylaminohexanoic acid (molecule 3), and the protecting group is removed under the action of strong organic acids (such as TFA, p-toluenesulfonic acid) to obtain molecule 4 with a diamino group at the end of the side chain; molecule 4 undergoes a nucleophilic substitution reaction with pentafluorophenyl tert-butoxycarbonylaminooxyacetate (molecule 5), and the protecting group is removed again to obtain molecule 6 with an active amino group at the end; the amino group at the end of molecule 6 undergoes a substitution reaction with the hydroxyl group at the end of oligoethylene glycol or oligosaccharide molecules to obtain the target product 7.

[0031] More preferably, it is prepared according to the following synthetic route:

[0032]

[0033] (1) Under the action of an initiator, the acid anhydride molecule 1 in the lysine-N-carboxyl ring undergoes ring-opening polymerization, and the protecting group is removed under the action of trifluoroacetic acid to obtain α-polylysine, i.e. molecule 2.

[0034] (2) Molecular 2 and molecule 3 undergo a dehydration condensation reaction and remove the protecting group to obtain molecule 4 with a diamino end of the side chain.

[0035] (3) Molecules 4 and 5 undergo nucleophilic substitution reaction and lose the protecting group to obtain molecule 6 with an active amino group at the end.

[0036] (4) The amino group at the end of molecule 6 and the hydroxyl group at the end of oligoethylene glycol or oligosaccharide molecule undergo a substitution reaction to obtain the target product 7.

[0037] All of the above-mentioned raw materials used in this invention can be prepared in-house or purchased commercially; this invention does not impose any particular limitations on them.

[0038] As can be seen from the above examples of synthesis methods, the lysine grafted polymer disclosed in this invention is simple to synthesize, and derivatives with different side chains can be obtained by only a few consecutive identical reactions.

[0039] Secondly, the present invention provides a method for preparing the above-mentioned polylysine grafted polymer, wherein the polylysine grafted polymer is prepared by method (1) lysine-N-carboxyl ring-opening anhydride polymerization or method (2) lysine α-amino dehydration condensation; preferably,

[0040] The method (1) is selected from either the ε-amino branching modification method before polymerization (1-1) or the ε-amino branching modification method after polymerization (1-2);

[0041] The method (2) is selected from either the ε-amino branching modification method before dehydration condensation (2-1) or the ε-amino branching modification method after dehydration condensation (1-2).

[0042] As a specific embodiment of the present invention, preferably, the preparation method includes the following steps:

[0043] (1) ε-Amino protection: Tert-butoxycarbonylation or benzyloxycarbonylation is used to protect the ε-amino group of lysine-N-carboxy ring anhydride to obtain lysine-N-carboxy ring anhydride with ε-amino protection.

[0044] (2) Polymerization reaction: The ε-amino-protected lysine-N-carboxyl anhydride is subjected to ring-opening polymerization under the action of an initiator, followed by deprotection of the protecting group under the action of a strong organic acid catalyst to obtain α-polylysine; more preferably, the initiator is terminated by an amino-containing alkyl carbon chain or an ethoxy chain, and even more preferably, the initiator has a structure shown in any one of formulas (IX)-(X).

[0045]

[0046] In equations (IX) and (X), 5 ≤ z ≤ 20;

[0047] Alternatively, the initiator may be terminally an alkyl carbon chain; more preferably, the initiator may have a structure shown in any one of formulas (VII-VIII).

[0048]

[0049] In equations (VII) and (VIII), 5 ≤ z ≤ 20; 2 ≤ y ≤ 8;

[0050] (3) Grafting reaction: α-polylysine undergoes a condensation reaction with 2,6-di-tert-butoxycarbonylaminohexanoic acid, and the protecting group is removed under the action of a strong organic acid catalyst. It then undergoes a nucleophilic substitution reaction with tert-butoxycarbonylaminooxyacetic acid pentafluorophenyl ester, and the protecting group is removed again to obtain an active amino group. The amino group then undergoes a substitution reaction with the hydroxyl groups at the end of the oligoethylene glycol or oligosaccharide molecule to obtain the target product.

[0051] Preferably, the strong organic acid catalysts in steps (2) and (3) are each independently selected from at least one of trifluoroacetic acid and p-toluenesulfonic acid.

[0052] Thirdly, the present invention provides a microfluidic chip whose interfaces are partially or entirely modified by the aforementioned lysine-grafted polymer.

[0053] In a specific embodiment of the present invention, preferably, the substrate of the microfluidic chip is glass or silicon wafer material.

[0054] Fourthly, the present invention provides a detection device, including the microfluidic chip described above.

[0055] As a specific embodiment of the present invention, the detection device can be used for the separation of cell-free DNA in blood, immunoassay, etc.

[0056] The beneficial effects of this invention are as follows:

[0057] The graft polymer disclosed herein comprises a main chain formed by polymerization of lysine monomers and side chains formed by grafting lysine. The side chains contain one or more reactive functional groups for coupling reactions with molecules containing alkoxy units to form alkoxy-containing side chain tail chains. This structure has the following advantages:

[0058] (1) Since the main chain is a hydrophobic peptide bond and the side chain and tail chain are hydrophilic groups, the polymer can be arranged in a regular helical structure on the chip interface. At the same time, the alkoxy groups of the side chain and tail chain can also be evenly and densely distributed on the chip interface, thereby greatly reducing the defects of the chip interface and reducing the non-specific adsorption of nucleic acids, proteins and cells on the chip interface.

[0059] (2) Since the lysine side chain is a branched structure, multiple functional side chain tail chains can be derived from it. Therefore, the numerous alkoxy tail chains uniformly arranged around the helical structure form a complete physical barrier on the substrate surface to block the non-specific adsorption of biomolecules on the substrate surface.

[0060] In summary, this polymer, when used for interface modification of microfluidic chips, can significantly reduce their non-specific adsorption to nucleic acids, proteins, and cells, thus helping to improve the sensitivity and practicality of microfluidic chips in biological detection. Attached Figure Description

[0061] Figure 1 This is a schematic diagram of the surface structure of the P(Lys-EG1) modified glass chip prepared in Example 4 of the present invention;

[0062] Figure 2 This is a schematic diagram of the glass-based chip channel in the detection device provided in Example 5;

[0063] 1. Microfluidic channel; 11. Sample inlet channel; 12. Reaction channel; 13. Sample outlet channel.

[0064] 2. Color development area, 21. Sample capture color development area, 22. Sample capture color development area. Detailed Implementation

[0065] The present invention will be further described below with reference to specific embodiments, but this does not constitute any limitation on the present invention.

[0066] The specific raw materials used in each embodiment of the present invention can be either self-made or commercially available, and the present invention does not impose any particular limitations on them.

[0067] The lysine-grafted polymer provided by this invention is preferably prepared according to the following synthetic route 1:

[0068]

[0069] (1) Under the action of an initiator, the acid anhydride molecule 1 in the lysine-N-carboxyl ring undergoes ring-opening polymerization, and the protecting group is removed under the action of trifluoroacetic acid to obtain α-polylysine, i.e. molecule 2.

[0070] (2) Molecular 2 and molecule 3 undergo a dehydration condensation reaction and remove the protecting group to obtain molecule 4 with a diamino end of the side chain.

[0071] (3) Molecules 4 and 5 undergo nucleophilic substitution reaction and lose the protecting group to obtain molecule 6 with an active amino group at the end.

[0072] (4) The amino group at the end of molecule 6 and the hydroxyl group at the end of oligoethylene glycol or oligosaccharide molecule undergo a substitution reaction to obtain the target product 7.

[0073] (I) Preparation of Lysine Grafted Polymers

[0074] Example 1

[0075] Synthesis of branched polymer P(Lys-EG1) with an oligoethylene glycol molecule in the lysine side chain

[0076] (1) Referring to synthetic route 1, molecule 2 was obtained by ring-opening polymerization of molecule 1. In anhydrous tetrahydrofuran, anhydrous N,N-dimethylformamide or N-methylpyrrolidone solvent (1.0 mL), tert-butoxycarbonyl (Boc) protected lysine-N-carboxyl ring anhydride (0.15 mmol) was stirred overnight (15 h) at room temperature (27 °C) with dodecylamine (0.0075 mmol) as initiator, and then ring-opened polymerized. The Boc protecting group was then removed by reacting in 2 mL of trifluoroacetic acid (TFA) and dichloromethane mixed solvent (v:v = 1:1) at room temperature (27 °C) for 0.5 h to obtain α-polylysine as shown in molecule 2.

[0077] (2) A solution of tert-butyloxycarbonylaminooxyacetic acid (15.5 mmol) and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) (18.6 mmol) in dichloromethane (50 mL) was cooled to zero degrees on ice, and then a solution of pentafluorophenol (17.1 mmol) in dichloromethane (5 mL) was added. The mixture was then gradually restored to room temperature (27 °C) and stirred for 5 hours to obtain pentafluorophenyl tert-butyloxycarbonylaminooxyacetic acid, i.e., molecule 5.

[0078] (3) Molecule 6-1 was prepared by reacting molecules 2 and 5 (similar in structure to molecule 6 in synthetic route 1, but with different degree of branching).

[0079]

[0080] Molecular 2 (1.30 mmol) and N,N-diisopropylethylamine (DIPEA) (3.88 mmol) were dissolved in 1 mL of DMSO, and then molecular 5 (25.0 mmol) was added. The resulting reaction mixture was stirred at room temperature for 1 hour, and after adding 2 mL of methanol, it was precipitated with diethyl ether. Then, 2 mL of trifluoroacetic acid (TFA) was added to the precipitated solid, and the mixture was stirred at room temperature for 0.5 hours. Excess TFA was removed by vacuum distillation, and 2 mL of methanol was added to the residue, which was then precipitated with diethyl ether to obtain molecule 6-1.

[0081] (4) The molecule having the structure of Formula 6-1, the oligoethylene glycol, and the aniline were dissolved in HAc / NaAc buffer (pH = 4.2); the reaction was carried out overnight at 37°C; after dialyzing with distilled water, the resulting solution was freeze-dried to obtain the branched polymer P (Lys-EG1). The molar ratio of the molecule of Formula 6-1, the oligoethylene glycol, and the aniline was 0.80:1.0:0.50.

[0082]

[0083] Example 2

[0084] Synthesis of branched polymer P(Lys-EG2) with two oligoethylene glycol molecules in the lysine side chain

[0085] The synthesis of the branched polymer P(Lys-EG2) differs from the synthesis of P(Lys-EG1) in Example 1 only in the preparation of molecule 4; the remaining steps are the same. Molecule 4 is prepared by placing molecules 2 and 3 in a mixed solvent of dichloromethane and hydroxybenzotriazole, followed by EDC-catalyzed condensation. Specifically, the steps are as follows:

[0086] Boc-Lys(Boc)-OH (molecule 3, 20.1 mmol), EDC (23.0 mmol), and hydroxybenzotriazole (23.0 mmol) were dissolved in dichloromethane (50 mL) and cooled to 0°C on ice. Then, N,N-diisopropylethylamine (26.0 mmol) and molecule 2 (1.30 mmol) were slowly added sequentially, and the mixture was allowed to return to room temperature (27°C) and reacted overnight (15 hours). After the reaction was complete, the mixture was washed once with 2 M (mol / L) hydrochloric acid, and then separated by silica gel column chromatography.

[0087] The final structure of the branched polymer P(Lys-EG2) is as follows:

[0088]

[0089] Example 3

[0090] Synthesis of branched polymer P(Lys-EG4) with four oligoethylene glycol molecules in the lysine side chain

[0091] The only difference between the branched polymer P (Lys-EG4) and the branched polymer P (Lys-EG2) in Example 2 is that molecule 4-3 is further prepared based on molecule 4 (similar in structure to molecule 4 in synthetic route 1, but with a different degree of branching). The rest of the methods are the same.

[0092]

[0093] Preparation of molecule 4-3: molecule 4-3 was obtained by condensation of molecule 4 (1.30 mmol) and molecule 3 (Boc-Lys(Boc)-OH, 38.0 mmol) in a mixed solvent of dichloromethane (50 mL) and hydroxybenzotriazole (23.0 mmol) catalyzed by EDC (23.0 mmol); the specific experimental steps were the same as those for the preparation of molecule 4 in Example 2.

[0094] The final structure of the branched polymer P(Lys-EG4) is as follows:

[0095]

[0096] (II) Fabrication and Performance of Lysine-Grafted Polymer-Modified Microfluidic Chips

[0097] Example 4

[0098] P(Lys-EG1) Modification of Glass Surfaces and Its Adsorption Properties for Proteins and Nucleic Acids

[0099] 1. The silicon oxide on the chip surface is converted into silanol groups.

[0100] Glass chips with silicon oxide on their surface are placed in piranha solution and soaked for 10 hours at a temperature of 85°C-90°C. The piranha solution is composed of 98wt% concentrated sulfuric acid and 30wt% hydrogen peroxide, wherein the volume ratio of the concentrated sulfuric acid to the 30% hydrogen peroxide is 1:3.

[0101] Then, rinse the chip twice with deionized water. After rinsing, ultrasonically clean the chip in deionized water and then dry it with nitrogen gas for later use.

[0102] 2. Hydrophobic modification of glass chip surface.

[0103] A glass chip with silanol groups on its surface was immersed in a 0.5% (v / v) toluene solution of decaalkyltrimethoxysilane and soaked in a sealed container at 35°C for 30 hours. After the reaction was completed, the reaction solution was discarded, the chip was rinsed twice with deionized water, and then ultrasonically cleaned with deionized water for 5 minutes to remove impurities adhering to the chip; the chip was then dried with nitrogen gas.

[0104] 3. P(Lys-EG1) modified glass chip

[0105] Using the branched polylysine P (Lys-EG1) prepared in Example 1, a solution with a concentration of 5.0 mg / mL was prepared with PBS buffer (pH 7.4). The cleaned glass chip was then immersed in the polymer solution and incubated at room temperature on a shaker for 24 hours. Finally, the coated glass chip was thoroughly rinsed with ultrapure water and dried with a nitrogen stream.

[0106] The steps for modifying glass chips with branched polylysine P (Lys-EG2) prepared in Example 2 and branched polylysine P (Lys-EG4) prepared in Example 3 are the same as those described above.

[0107] The preparation method of PEG-coated glass chips is the same as the above steps, and the PEG used is hexadecyl polyoxyethylene ether.

[0108] 4. Protein and nucleic acid adsorption experiments

[0109] Bare glass chips without polymer coating, glass chips with grafted polymer (P(Lys-EG1), P(Lys-EG2), P(Lys-EG4)) coating, and glass chips with PEG coating were rinsed with PBS buffer. At 25°C, freshly prepared protein solutions (BSA, 1.0 mg / mL) or oligonucleotide solutions (21 nt-dsDNA, 1.5 mg / mL) were flowed through the chips at a flow rate of 50 μL / min for 15 minutes, followed by rinsing the chip surface with PBS buffer for 15 minutes. The amount of protein and oligonucleotides adsorbed on the glass surface was determined by measuring the fluorescent groups modified with these molecules. The results are shown in Table 1.

[0110] Table 1

[0111] 21nt dsDNA BSA Bare Glass 100% 100% <![CDATA[P(Lys-EG1)]]> 3.2% 4.0% <![CDATA[P(Lys-EG2)]]> 3.4% 3.7% <![CDATA[P(Lys-E4)]]> 2.7% 2.9% PEG 10.2% 13.0%

[0112] As shown in Table 1, compared with PEG, the lysine-grafted polymer disclosed in this invention can significantly reduce its non-specific adsorption of oligonucleotides and proteins after coating the glass interface. Moreover, from P(Lys-EG1) to P(Lys-EG2) and then to P(Lys-EG4), the non-specific "zero" adsorption effect becomes more obvious as the number of branched side chain terminal oligoethylene glycols increases.

[0113] (III) Detection Device

[0114] Example 5

[0115] This embodiment provides a detection device comprising a glass chip with a P(Lys-EG1) coating prepared in Example 4, used to achieve non-specific "zero" adsorption of the analyte and improve the signal-to-noise ratio at the detection site. This detection device is used for biological detection; the structure of its glass-based chip channel is described in [reference needed]. Figure 2 As shown, the microfluidic channel 1 includes an inlet channel 11, a reaction channel 12, and an outlet channel 13; the color development area 2 includes a sample capture color development area 21 disposed between the inlet channel 11 and the reaction channel 12, and a sample capture color development area 22 disposed between the reaction channel 12 and the outlet channel 13.

[0116] To avoid non-specific adsorption of the sample on the glass substrate surface during flow, which would reduce the sensitivity of the experiment, this embodiment applies a P(Lys-EG1) coating to the inlet channel 11, reaction channel 12, and outlet channel 13, respectively, as in Example 4. The reactions occurring in the sample capture and color development regions 21 and 22 can be oligonucleotide single-chain hybridization capture reactions or antigen-antibody specific recognition reactions, and can be designed according to specific experimental details; no further restrictions are imposed here.

[0117] Of course, in other embodiments, the coating can be applied to all or part of the color development area 2 at the same time, leaving only the area to be reacted.

[0118] In summary, the graft polymer provided in this disclosure comprises a main chain formed by polymerizing lysine monomers and side chains formed by grafting lysine. The side chains contain one or more reactive functional groups for coupling reactions with molecules containing alkoxy units to form alkoxy-containing side chain tail chains. This polymer, used for interface modification of microfluidic chips, can significantly reduce their non-specific adsorption to nucleic acids, proteins, and cells, thus contributing to improved sensitivity and practicality of microfluidic chips in biological detection. The structure of this polymer has the following advantages:

[0119] (1) Since the main chain is a hydrophobic peptide bond and the side chain and tail chain are hydrophilic groups, the polymer can be arranged in a regular helical structure on the chip interface. At the same time, the alkoxy groups of the side chain and tail chain can also be evenly and densely distributed on the chip interface, thereby greatly reducing the defects of the chip interface and reducing the non-specific adsorption of nucleic acids, proteins and cells on the chip interface.

[0120] (2) Since the lysine side chain is a branched structure, multiple functional side chain tail chains can be derived from it. Therefore, the numerous alkoxy tail chains uniformly arranged around the helical structure form a complete physical barrier on the substrate surface to block the non-specific adsorption of biomolecules on the substrate surface.

[0121] Any numerical value mentioned in this invention, if there is only a two-unit interval between any minimum and any maximum value, includes all values ​​that increase by one unit each time from the minimum to the maximum value. For example, if the amount of a component, or the value of a process variable such as temperature, pressure, or time, is stated as 50-90, in this specification it means specifically listing values ​​such as 51-89, 52-88… and 69-71 and 70-71, etc. For non-integer values, it may be appropriately considered that a unit is 0.1, 0.01, 0.001, or 0.0001. These are merely some specifically specified examples. In this application, in a similar manner, all possible combinations of numerical values ​​between the listed minimum and maximum values ​​are considered to have been disclosed.

[0122] It should be noted that the embodiments described above are only for explaining the present invention and do not constitute any limitation on the present invention. The present invention has been described with reference to typical embodiments, but it should be understood that the words used therein are descriptive and explanatory terms, not limiting terms. Modifications can be made to the present invention within the scope of the claims, and revisions can be made to the present invention without departing from the scope and spirit of the present invention. Although the present invention described herein relates to specific methods, materials, and embodiments, it does not mean that the present invention is limited to the specific examples disclosed herein; on the contrary, the present invention can be extended to all other methods and applications with the same function.

Claims

1. A polylysine-grafted polymer, characterized in that, It has the structure shown in equation (I): Formula (I) Where 10≤n≤50, R' is a tail chain group, and R1 has the structure shown in any one of formulas (II)-(IV). Wherein, R2 has the structure shown in equation (V), Equation (V) Where 2≤m≤10; R' has the structure shown in any one of equations (VII)-(VIII), Equation (VII) Equation (VIII) Where 5≤z≤20; 2≤y≤8.

2. The polymer according to claim 1, characterized in that, 15≤n≤25。 3. The polymer according to claim 2, characterized in that, n is 15, 18, 20, 22 or 25.

4. The polymer according to any one of claims 1-3, characterized in that, 3≤m≤6。 5. The polymer according to claim 4, characterized in that, m can be 3, 4, 5, or 6.

6. A method for preparing the polylysine-grafted polymer according to any one of claims 1-5, characterized in that, Includes the following steps: (1) ε-Amino protection: tert-butoxycarbonylation or benzyloxycarbonylation is used to protect the ε-amino group of lysine-N-carboxy ring anhydride to obtain lysine-N-carboxy ring anhydride with ε-amino protection. (2) Polymerization reaction: The ε-amino protected lysine-N-carboxyl anhydride is ring-opened polymerized under the action of an initiator, and then the protecting group is removed under the action of a strong organic acid catalyst to obtain α-polylysine; (3) Grafting reaction: α-polylysine undergoes a condensation reaction with 2,6-di-tert-butoxycarbonylaminohexanoic acid, and the protecting group is removed under the action of a strong organic acid catalyst. It then undergoes a nucleophilic substitution reaction with tert-butoxycarbonylaminooxyacetic acid pentafluorophenyl ester, and the protecting group is removed again to obtain an active amino group. The amino group then undergoes a substitution reaction with oligoethylene glycol to obtain the target product. The initiator is terminally composed of an amino-containing alkyl carbon chain; the initiator terminally has a structure shown in any one of formulas (VII-VIII). Equation (VII) Equation (VIII) In equations (VII) and (VIII), 5 ≤ z ≤ 20; 2 ≤ y ≤ 8.

7. The preparation method according to claim 6, characterized in that, The strong organic acid catalysts mentioned in steps (2) and (3) are each independently selected from at least one of trifluoroacetic acid and p-toluenesulfonic acid.

8. A microfluidic chip, characterized in that, Its interface is partially or completely modified by the polylysine graft polymer as described in any one of claims 1-5, or by the polylysine graft polymer prepared by the preparation method described in claim 6 or 7.

9. The microfluidic chip according to claim 8, characterized in that, The substrate of the microfluidic chip is glass or silicon wafer.

10. A detection device, characterized in that, It includes the microfluidic chip as described in claim 8 or 9.

Citation Information

Patent Citations

  • Amphiphilic polymer for surface biological functionalization and preparation method and use thereof

    CN112442179A

  • Micro flow control chip of silicon rubber and method for face finish

    CN1627069A